Literature DB >> 6356187

Transferable plasmid-mediated antibiotic resistance in Acinetobacter.

F W Goldstein, A Labigne-Roussel, G Gerbaud, C Carlier, E Collatz, P Courvalin.   

Abstract

Acinetobacter calcoaceticus strain BM2500 was resistant to ampicillin, aminoglycoside-aminocyclitols, chloramphenicol, sulfonamides, and high levels of trimethoprim. Resistance to ampicillin was due to the presence of a beta-lactamase (TEM-1) and the aminoglycoside-aminocyclitol resistance was mediated by phosphotransferase (APH(3')(5")I) and adenylyltransferase (AAD(3)(9] activities. The resistance genes were carried by a 167 kilobase plasmid, pIP1031, belonging to incompatibility group 6-C; the plasmid was self-transferable, at extremely low frequency, to Escherichia coli by conjugation. Plasmid pIP1031 DNA was analyzed by agarose gel electrophoresis following restriction endonuclease digestion, by nucleic acid hybridization, and by CsCl analytical density gradient ultracentrifugation. The results support the hypothesis that plasmid pIP1031 may have been acquired recently by strain BM2500.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356187     DOI: 10.1016/0147-619x(83)90066-5

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  25 in total

1.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 2.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

3.  Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp.

Authors:  T Lambert; G Gerbaud; P Bouvet; J F Vieu; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 4.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.

Authors:  Sébastien Coyne; Ghislaine Guigon; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

6.  Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.

Authors:  M B Marques; E S Brookings; S A Moser; P B Sonke; K B Waites
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Transferable amikacin resistance in pseudomonas maltophilia and acinetobacter calcoaceticus.

Authors:  V Krcméry; M Antal; L Langsádl; H Knothe
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553

8.  Molecular analysis of multiple-resistance plasmids transferred from gram-negative bacteria isolated in a urological unit.

Authors:  H G Griffin; T J Foster; F R Falkiner; M E Carr; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

9.  Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Authors:  J Vila; J Ruiz; M Navia; B Becerril; I Garcia; S Perea; I Lopez-Hernandez; I Alamo; F Ballester; A M Planes; J Martinez-Beltran; T J de Anta
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.